These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 856754)

  • 1. Comparative efficacy of coronary vasodilatory methods.
    Bookstein JJ; Higgins CB
    Invest Radiol; 1977; 12(2):121-7. PubMed ID: 856754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans.
    De Bruyne B; Pijls NH; Barbato E; Bartunek J; Bech JW; Wijns W; Heyndrickx GR
    Circulation; 2003 Apr; 107(14):1877-83. PubMed ID: 12668522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measurement of coronary flow reserve using adenosine 5'-triphosphate in dogs].
    Kohno H; Yamada H; Azuma A; Kondo M; Yagi T; Kawata K; Tatsukawa H; Sugihara H; Nakagawa M
    J Cardiol; 1998 Jul; 32(1):1-8. PubMed ID: 9739511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of adenosine triphosphate on human coronary circulation.
    Shiode N; Kato M; Nakayama K; Shinohara K; Kurokawa J; Yamagata T; Matsuura H; Kajiyama G
    Intern Med; 1998 Oct; 37(10):818-25. PubMed ID: 9840701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary vasodilator reserve. Comparison of the effects of papaverine and adenosine on coronary flow, ventricular function, and myocardial metabolism.
    Christensen CW; Rosen LB; Gal RA; Haseeb M; Lassar TA; Port SC
    Circulation; 1991 Jan; 83(1):294-303. PubMed ID: 1984887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious humans.
    Wilson RF; White CW
    Circulation; 1986 Mar; 73(3):444-51. PubMed ID: 3948354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative hemodynamic effects of coronary vasodilators and contrast material on the normal and ischemic canine myocardium: determination of the optimal agent for clinical augmentation of coronary blood flow.
    Higgins CB; Bookstein JJ
    Invest Radiol; 1977; 12(4):299-306. PubMed ID: 407173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary microvascular response to intracoronary administration of nicorandil.
    Hongo M; Takenaka H; Uchikawa S; Nakatsuka T; Watanabe N; Sekiguchi M
    Am J Cardiol; 1995 Feb; 75(4):246-50. PubMed ID: 7832132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of intracoronary papaverine, alprostadil, and high dosages of nicorandil and adenosine triphosphate for measurement of the index of coronary microcirculatory resistance in a pig model.
    Duan T; Zhang J; Xiang D; Song R; Kong R; Xu D
    Adv Clin Exp Med; 2019 Oct; 28(10):1409-1418. PubMed ID: 31638745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and optimal dose of intracoronary adenosine 5'-triphosphate for the measurement of coronary flow reserve.
    Sonoda S; Takeuchi M; Nakashima Y; Kuroiwa A
    Am Heart J; 1998 Apr; 135(4):621-7. PubMed ID: 9539477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intracoronary adenosine triphosphate on coronary flow velocity dynamics in children.
    Hamaoka K; Onouchi Z
    Jpn Heart J; 1997 Jan; 38(1):39-52. PubMed ID: 9186280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of caffeine on fractional flow reserve values measured using intravenous adenosine triphosphate.
    Nakayama M; Chikamori T; Uchiyama T; Kimura Y; Hijikata N; Ito R; Yuhara M; Sato H; Kobori Y; Yamashina A
    Cardiovasc Interv Ther; 2018 Apr; 33(2):116-124. PubMed ID: 28110424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous adenosine: continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease.
    Kern MJ; Deligonul U; Tatineni S; Serota H; Aguirre F; Hilton TC
    J Am Coll Cardiol; 1991 Sep; 18(3):718-29. PubMed ID: 1869735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value and limitations of intracoronary adenosine for the assessment of coronary flow reserve.
    Zijlstra F; Juillière Y; Serruys PW; Roelandt JR
    Cathet Cardiovasc Diagn; 1988; 15(2):76-80. PubMed ID: 3180211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of adenosine on human coronary arterial circulation.
    Wilson RF; Wyche K; Christensen BV; Zimmer S; Laxson DD
    Circulation; 1990 Nov; 82(5):1595-606. PubMed ID: 2225364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Can adenosine triphosphate induce maximal hyperemic response in patients with impaired coronary microcirculation?: comparison of hyperemic response to adenosine triphosphate administered by intravenous and by intracoronary injection using Doppler guide wire].
    Yanagi S; Hirota K; Nagae K; Abe Y; Hasegawa T; Okada M; Ota T; Yoshikawa J
    J Cardiol; 2002 Jan; 39(1):1-10. PubMed ID: 11828792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracoronary administration of adenosine triphosphate increases myocardial adenosine levels and coronary blood flow in man.
    Nanto S; Kitakaze M; Takano Y; Hori M; Nagata S
    Jpn Circ J; 1997 Oct; 61(10):836-42. PubMed ID: 9387065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global and regional ventricular function following intracoronary application of papaverine.
    Schad H; Heimisch W; Haas F; Blasini R; Mendler N
    Eur J Cardiothorac Surg; 1991; 5(11):598-602. PubMed ID: 1772671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Coronary flow after successful angioplasty in patients with acute myocardial infarction: comparison between coronary flow reserve by nicorandil and papaverine].
    Izumi C; Kondo H; Tamura T; Inoko M; Kitaguchi S; Hirozane T; Himura Y; Iga K; Gen H; Konishi T
    J Cardiol; 2000 Mar; 35(3):175-80. PubMed ID: 10808424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasodilator action of KB-944, a new calcium antagonist.
    Morita T; Yoshino K; Kanazawa T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1037-42. PubMed ID: 6890822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.